The Long Run with Luke Timmerman

Ep150: Jeff Jonker on the Small Molecule Drug Discovery Renaissance

Dec 13, 2023
Guest
Jeff Jonker
Jeff Jonker, CEO of Belharra Therapeutics, discusses the renaissance in small molecule drug discovery. Topics include their accidental entry into biotech, the significance of building relationships in the industry, the appeal of sustainable platform companies, chemo proteomics, small molecule binders and covalent bonds in drug discovery, and covalent and non-covalent binding in small molecule drug discovery.
Ask episode
Chapters
Transcript
Episode notes
1
Introduction
00:00 • 2min
2
Stumbling into the Biotech Industry
01:44 • 21min
3
The Importance of Building Relationships in the Industry
23:12 • 3min
4
The Appeal of Being Part of a Sustainable Platform Company
26:12 • 4min
5
Chemo Proteomics: Identifying Chemical-Protein Interactions
30:38 • 5min
6
Exploring Small Molecule Binders and Covalent Bonds in Drug Discovery
35:53 • 5min
7
Covalent and non-covalent binding in small molecule drug discovery
40:36 • 23min